The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

The pharmacy, a centuries-long institution and venerable presence in communities around the world, is evolving before our ...

President and CEO Ned McCoy shared with Becker's some of the company's key objectives for the year, including the launch of some of the first medications from its Petersburg, Va.-based plant, the ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

WORCESTER ― The City Council on Tuesday sent to the city manager’s desk a request for a report assessing the practices in the city of third-party companies that are intended to negotiate with drug ...

Pharma brands achieved the most impressions from ABC and saw a year-over-year increase in impressions from cable channels like Fox News, CNN and MSNBC.

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related disorders and USWM LLC, a specialty ...